A Clinical Trial of Mirabegron for Overactive Bladder Symptoms in Patients With Parkinson Disease and Impaired Cognition
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 25 Oct 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 25 Oct 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 02 Dec 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.